Cargando…
Lugtenburg PJ, Mutsaers PGNJ. How I treat older patients with DLBCL in the frontline setting. Blood. 2023;141(21):2566-2575.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644074/ https://www.ncbi.nlm.nih.gov/pubmed/37733375 http://dx.doi.org/10.1182/blood.2023021551 |
Ejemplares similares
-
Moujalled DM, Brown FC, Chua CC, et al. Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia. Blood. 2023;141(6):634-644.
Publicado: (2023) -
Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders. Int. J. Mol. Sci. 2010, 11, 2566–2575
por: Ando, Hideya, et al.
Publicado: (2010) -
Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients
por: Maillet, M., et al.
Publicado: (2013) -
PJ accu (?)
Publicado: (1989) -
2566. infection Dynamics of Pseudomonas aeruginosa Bloodstream Infections
por: Bachta, Kelly E R, et al.
Publicado: (2019)